Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine.
Toxicology mechanisms and methods March 2018 Daniel P Katz, Mohammed Majrashi, Sindhu Ramesh et al.
Benzylpiperazine has been designated as Schedule I substance under the Controlled Substances Act by Drug Enforcement Administration. Benzylpiperazine is a piperazine derivative, elevates both dopamine and serotonin extracellular levels producing stimulatory and hallucinogenic effects, respectively, similar to methylenedioxymethamphetamine (MDMA). However, the comparative neurotoxic effects of...
DOI: 10.1080/15376516.2017.1376024 (opens in new tab)
Full text (opens in new tab)
Piperazine designer drugs
Apoptosis
Mitochondrial functions
Monoamine neurotransmission
+1